New dementia drugs too costly, says clinician
The cost of a new wave of drugs to treat Alzheimer’s disease may be too prohibitive for many people living...
Donanemab
The cost of a new wave of drugs to treat Alzheimer’s disease may be too prohibitive for many people living...
Advertisement